John Morawetz

There was an amazing scene this week at the annual meeting of DuPont shareholders. The reporting by Jeff Mordock of the The News-Journal made me feel like I was in the room witnessing it for myself. Mordock writes: “DuPont Co.'s safety record - not its upcoming $130 billion merger with The Dow Chemical Co. - was the focus of shareholder's ire at the company's annual meeting in New York City Wednesday. Not one shareholder asked DuPont CEO Ed Breen a question about the merger…Instead, shareholders grilled Breen about recent deaths at DuPont plants, including that of four workers killed at its…